• LAST PRICE
    9.6200
  • TODAY'S CHANGE (%)
    Trending Down-0.2400 (-2.4341%)
  • Bid / Lots
    3.8600/ 2
  • Ask / Lots
    10.1000/ 2
  • Open / Previous Close
    9.7500 / 9.8600
  • Day Range
    Low 9.5600
    High 9.8200
  • 52 Week Range
    Low 3.8900
    High 10.0600
  • Volume
    66,326
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 9.86
TimeVolumeFENC
09:32 ET18299.59
09:33 ET2009.6457
09:39 ET4009.65
09:42 ET8009.75
09:46 ET24009.75
09:48 ET18909.68
09:50 ET1009.65
09:53 ET2009.59
09:55 ET4339.6116
10:04 ET53859.58
10:08 ET6009.635
10:09 ET2009.67
10:11 ET1009.695
10:15 ET4609.695
10:18 ET25519.7187
10:22 ET1009.8199
10:31 ET2009.82
10:36 ET16009.785
10:40 ET1009.74
10:49 ET6509.75
10:54 ET10009.7717
11:00 ET3269.79
11:02 ET3009.785
11:12 ET1009.76
11:14 ET5009.76
11:18 ET14009.7
11:39 ET3009.718
11:41 ET2579.7193
11:50 ET1009.73
12:12 ET6009.71
12:15 ET8009.7
12:17 ET11999.7
12:19 ET2229.71
12:26 ET1009.7
12:35 ET41589.65
12:39 ET6009.6163
12:57 ET3009.62
01:08 ET1009.61
01:11 ET2009.61
01:22 ET5009.59
01:24 ET7009.61
01:27 ET21009.62
01:44 ET1879.6557
02:00 ET3009.66
02:02 ET1009.66
02:14 ET1009.68
02:30 ET3009.71
02:41 ET2009.77
02:48 ET1009.77
02:57 ET2009.8
02:59 ET1009.82
03:03 ET6829.785
03:15 ET1009.725
03:17 ET2009.7473
03:21 ET1009.63
03:28 ET2009.65
03:32 ET4009.6
03:35 ET21419.65
03:37 ET6009.65
03:42 ET12009.65
03:46 ET1009.66
03:48 ET4929.66
03:51 ET2009.65
03:53 ET6459.67
03:55 ET60359.61
03:57 ET1009.61
04:00 ET17369.62
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFENC
Fennec Pharmaceuticals Inc
252.4M
-11.8x
---
United StatesTHRX
Theseus Pharmaceuticals Inc
252.4M
-5.6x
---
United StatesIVVD
Invivyd Inc
252.8M
-0.9x
---
United StatesANNX
Annexon Inc
255.3M
-1.6x
---
United StatesVAXX
Vaxxinity Inc
257.2M
-3.3x
---
United StatesOTLK
Outlook Therapeutics Inc
244.2M
-3.3x
---
As of 2022-12-03

Company Information

Fennec Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The Company’s only product candidate in the clinical stage of development is PEDMARK. It announced two results of Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children, including the pivotal Phase III study SIOPEL 6 and the proof-of-concept Phase III study in collaboration with the Children’s Oncology Group (COG ACCL0431). The Company’s four subsidiaries includes Oxiquant, Inc. and Fennec Pharmaceuticals, Inc., both Delaware corporations, Cadherin Biomedical Inc., a Canadian company, and Fennec Pharmaceuticals (EU) Limited (Fennec Limited), an Ireland company. Apart from Fennec Pharmaceuticals, Inc., all subsidiaries are inactive.

Contact Information

Headquarters
68 Tw Alexander Dr PO Box 13628RESEARCH TRIANGLE PARK, NC, United States 27709
Phone
919-636-4530
Fax
919-890-0490

Executives

Independent Chairman of the Board
Khalid Islam
Chief Executive Officer, Director
Rostislav Raykov
Chief Financial Officer
Robert Andrade
Chief Commercial Officer
Shubh Goel
Independent Director
Marco Brughera

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$252.4M
Revenue (TTM)
$0.00
Shares Outstanding
26.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.03
EPS
$-0.82
Book Value
$0.61
P/E Ratio
-11.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.